In mouse genetic studies, Tet1-deficient B cell progenitors developed B cells lymphomas (158); in analogous human studies, the Tet1 promoter was found to be hypermethylated with concomitant reduction in Tet1 expression in patients with non-Hodgkin lymphoma (158). Here, TET1 is linked to B-cell non-Hodgkin lymphoma.